TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Joel Neal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.